RecruitingNCT07460141

IL-6 and Hemogram-Derived Inflammatory Indices for Mortality Prediction in Postoperative ICU Patients

The Effects of IL-6 and Inflammation Scores on Mortality in Postoperative Patients Admitted to the Intensive Care Unit


Sponsor

Ezgi Günaydın

Enrollment

42 participants

Start Date

Dec 15, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This prospective observational cohort study aims to evaluate the predictive value of interleukin-6 (IL-6) levels and hemogram-derived inflammatory scores for morbidity and in-hospital mortality in postoperative patients admitted to the intensive care unit (ICU). IL-6 levels and inflammatory indices will be assessed at ICU admission and at 24 hours using data obtained from routine clinical care. Associations between these biomarkers and clinical outcomes, including mortality, morbidity, antibiotic use, and duration of mechanical ventilation, will be evaluated after adjustment for illness severity.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age ≥ 18 years
  • Postoperative patients admitted to the ICU
  • Availability of complete clinical and laboratory data at ICU admission and at 24 hours
  • Provision of informed consent by the patient or legally authorized representative

Exclusion Criteria3

  • Age \< 18 years
  • Thoracic surgery patients
  • Cardiac surgery patients

Locations(1)

Recep Erin

Trabzon, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07460141


Related Trials